scholarly journals Anti-MUC1 CAR-T cells combined with PD-1 knockout engineered T cells for patients with non-small cell lung cancer (NSCLC): A pilot study

2018 ◽  
Vol 29 ◽  
pp. x11
Author(s):  
S. Chen ◽  
Y. Lin ◽  
S. Zhong ◽  
H. An ◽  
Y. Lu ◽  
...  
Keyword(s):  
Lung Cancer ◽  
T Cells ◽  
Pilot Study ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Car T Cells ◽  
Car T ◽  
Engineered T Cells

scholarly journals LunX-CAR T Cells as a Targeted Therapy for Non-Small Cell Lung Cancer

2020 ◽  
Vol 17 ◽  
pp. 361-370 ◽  
Author(s):  
Ziming Hu ◽  
Xiaohu Zheng ◽  
Defeng Jiao ◽  
Yonggang Zhou ◽  
Rui Sun ◽  
...  
Keyword(s):  
Lung Cancer ◽  
T Cells ◽  
Targeted Therapy ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Car T Cells ◽  
Car T

scholarly journals Targeting PD-L1 in non-small cell lung cancer using CAR T cells

Oncogenesis ◽  
2020 ◽  
Vol 9 (8) ◽  
Author(s):  
Ming Liu ◽  
Xu Wang ◽  
Wei Li ◽  
Xinfang Yu ◽  
Pedro Flores-Villanueva ◽  
...  
Keyword(s):  
Lung Cancer ◽  
T Cells ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Car T Cells ◽  
Car T

A phase I trial of PD-1 deficient engineered T cells with CRISPR/Cas9 in patients with advanced non-small cell lung cancer.

2018 ◽  
Vol 36 (15_suppl) ◽  
pp. 3050-3050 ◽  
Author(s):  
You Lu ◽  
Jianxin Xue ◽  
Tao Deng ◽  
Xiaojuan Zhou ◽  
Kun Yu ◽  
...  
Keyword(s):  
Lung Cancer ◽  
T Cells ◽  
Phase I ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Phase I Trial ◽  
Small Cell ◽  
Small Cell Lung ◽  
Engineered T Cells
Sign in / Sign up

Export Citation Format

Share Document